Characterization of the colistin (polymyxin E1 and E2) biosynthetic gene cluster

[1]  J. Vederas,et al.  Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates , 2016, Medicinal research reviews.

[2]  Brian T. Tsuji,et al.  Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. , 2015, The Lancet. Infectious diseases.

[3]  G. Rossolini,et al.  Update on the antibiotic resistance crisis. , 2014, Current opinion in pharmacology.

[4]  J. Partridge,et al.  Photon Hunting in the Twilight Zone: Visual Features of Mesopelagic Bioluminescent Sharks , 2014, PloS one.

[5]  Géraldine Klein,et al.  Novel nonribosomal peptide synthetase (NRPS) genes sequenced from intertidal mudflat bacteria. , 2014, FEMS microbiology letters.

[6]  J. Li,et al.  Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’ , 2014, ACS chemical biology.

[7]  D. Drider,et al.  What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe? , 2013, International journal of antimicrobial agents.

[8]  R. Nagaraj,et al.  Effect of Selectively Introducing Arginine and D-Amino Acids on the Antimicrobial Activity and Salt Sensitivity in Analogs of Human Beta-Defensins , 2013, PloS one.

[9]  J. Blom,et al.  Polymyxin P is the active principle in suppressing phytopathogenic Erwinia spp. by the biocontrol rhizobacterium Paenibacillus polymyxa M-1 , 2013, BMC Microbiology.

[10]  R. Nation,et al.  Pharmacology of polymyxins: new insights into an 'old' class of antibiotics. , 2013, Future microbiology.

[11]  D. Hober,et al.  Synergistic Effect between Colistin and Bacteriocins in Controlling Gram-Negative Pathogens and Their Potential To Reduce Antibiotic Toxicity in Mammalian Epithelial Cells , 2013, Antimicrobial Agents and Chemotherapy.

[12]  J. Hoogmartens,et al.  A Novel Depsipeptide Produced by Paenibacillus alvei 32 Isolated from a Cystic fibrosis Patient , 2012, Probiotics and Antimicrobial Proteins.

[13]  R. Hammami,et al.  Colistin A and colistin B among inhibitory substances of Paenibacillus polymyxa JB05-01-1 , 2012, Archives of Microbiology.

[14]  J. Vederas,et al.  Paenibacillus polymyxa PKB1 produces variants of polymyxin B-type antibiotics. , 2011, Chemistry & biology.

[15]  Kai Blin,et al.  NRPSpredictor2—a web server for predicting NRPS adenylation domain specificity , 2011, Nucleic Acids Res..

[16]  D. Drider,et al.  Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli. , 2011, Research in microbiology.

[17]  O. Kuipers,et al.  Prokaryotic Antimicrobial Peptides. From Genes to Applications , 2011 .

[18]  S. Rebuffat,et al.  Prokaryotic antimicrobial peptides , 2011 .

[19]  M. Marahiel,et al.  Nonribosomal peptide synthetases: structures and dynamics. , 2010, Current opinion in structural biology.

[20]  Jian Li,et al.  Structure--activity relationships of polymyxin antibiotics. , 2010, Journal of medicinal chemistry.

[21]  D. Drider,et al.  Nisin A and Polymyxin B as Synergistic Inhibitors of Gram-positive and Gram-negative Bacteria , 2010, Probiotics and antimicrobial proteins.

[22]  Jihyun F. Kim,et al.  Identification of a Polymyxin Synthetase Gene Cluster of Paenibacillus polymyxa and Heterologous Expression of the Gene in Bacillus subtilis , 2009, Journal of bacteriology.

[23]  Jacques Ravel,et al.  Chapter 8. Methods for in silico prediction of microbial polyketide and nonribosomal peptide biosynthetic pathways from DNA sequence data. , 2009, Methods in enzymology.

[24]  Valérie Sopéna,et al.  Megamonas rupellensis sp. nov., an anaerobe isolated from the caecum of a duck. , 2008, International journal of systematic and evolutionary microbiology.

[25]  T. Souto-Padrón,et al.  Antimicrobial activity of Paenibacillus polymyxa SCE2 against some mycotoxin‐producing fungi , 2008, Journal of applied microbiology.

[26]  M. Falagas,et al.  Potential of old-generation antibiotics to address current need for new antibiotics , 2008, Expert review of anti-infective therapy.

[27]  M. Takano,et al.  Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents , 2008, Antimicrobial Agents and Chemotherapy.

[28]  V. Tam,et al.  Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms , 2008, Expert opinion on investigational drugs.

[29]  V. Tam,et al.  Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms. , 2008, Expert opinion on investigational drugs.

[30]  E. Desantis,et al.  Resurgence of colistin use. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[31]  J. Peterson,et al.  Polymyxin E production by P. amylolyticus , 2007, Letters in applied microbiology.

[32]  Saleh Shah,et al.  Use of PCR-Targeted Mutagenesis To Disrupt Production of Fusaricidin-Type Antifungal Antibiotics in Paenibacillus polymyxa , 2007, Applied and Environmental Microbiology.

[33]  M. Falagas,et al.  Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[34]  M. Falagas,et al.  Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials , 2006, Critical care.

[35]  H. Yoneyama,et al.  Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development , 2006, Bioscience, biotechnology, and biochemistry.

[36]  M. Falagas,et al.  Reaction to the threat of influenza pandemic: the mass media and the public , 2006, Critical care.

[37]  Lisbeth Olsson,et al.  Determination of cell mass and polymyxin using multi-wavelength fluorescence. , 2006, Journal of biotechnology.

[38]  M. Falagas,et al.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies , 2006, Critical care.

[39]  G. Araj,et al.  Detection of a highly prevalent and potentially virulent strain of Pseudomonas aeruginosa from nosocomial infections in a medical center , 2005, BMC Microbiology.

[40]  Matthew E Falagas,et al.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  R. Studer,et al.  The chemistry of the polymyxin antibiotics , 1966, Experientia.

[42]  R. Ashley,et al.  Surface expression, single-channel analysis and membrane topology of recombinant Chlamydia trachomatis Major Outer Membrane Protein , 2005, BMC Microbiology.

[43]  R. Hodges,et al.  Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. , 2004, The journal of peptide research : official journal of the American Peptide Society.

[44]  F. Reynaldi,et al.  Inhibition of the growth of Ascosphaera apis by Bacillus and Paenibacillus strains isolated from honey. , 2004, Revista Argentina de microbiologia.

[45]  M. Marahiel,et al.  Nonribosomal peptides: from genes to products. , 2003, Natural product reports.

[46]  J. Vederas,et al.  Isolation, Structural Characterization, and Properties of Mattacin (Polymyxin M), a Cyclic Peptide Antibiotic Produced byPaenibacillus kobensis M* , 2003, The Journal of Biological Chemistry.

[47]  A. Van Schepdael,et al.  Liquid chromatography-ion trap tandem mass spectrometry for the characterization of polypeptide antibiotics of the colistin series in commercial samples. , 2002, Journal of chromatography. A.

[48]  A. Van Schepdael,et al.  Study of the stability of polymyxins B(1), E(1) and E(2) in aqueous solution using liquid chromatography and mass spectrometry. , 2002, Journal of pharmaceutical and biomedical analysis.

[49]  D. Livermore,et al.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  E. Roets,et al.  Characterization of Polypeptide Antibiotics of the Polymyxin Series by Liquid Chromatography Electrospray Ionization Ion Trap Tandem Mass Spectrometry , 2002, Journal of peptide science : an official publication of the European Peptide Society.

[51]  S. Jensen,et al.  Paenibacillus polymyxa produces fusaricidin-type antifungal antibiotics active against Leptosphaeria maculans, the causative agent of blackleg disease of canola. , 2002, Canadian journal of microbiology.

[52]  K. Lee,et al.  Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. , 1999, Biochemical pharmacology.

[53]  T. Stachelhaus,et al.  The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases. , 1999, Chemistry & biology.

[54]  Mohamed A. Marahiel,et al.  Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis. , 1997, Chemical reviews.

[55]  P. Brick,et al.  Structural basis for the activation of phenylalanine in the non‐ribosomal biosynthesis of gramicidin S , 1997, The EMBO journal.

[56]  D. Thouvenot,et al.  Gavaserin and saltavalin, new peptide antibiotics produced by Bacillus polymyxa. , 1995, FEMS microbiology letters.

[57]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[58]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[59]  S. Wilkinson,et al.  Structures of the Polymyxins A and the Question of Identity with the Polymyxins M , 1966, Nature.

[60]  B. A. Newton.  The properties and mode of action of the polymyxins. , 1956, Bacteriological reviews.

[61]  P. Stansly.  The polymyxins; a review and assessment. , 1949, The American journal of medicine.

[62]  R. G. Benedict,et al.  EFFECT OF VARIOUS FACTORS ON THE PRODUCTION OF POLYMYXIN , 1949, Annals of the New York Academy of Sciences.

[63]  P. Stansly,et al.  Studies on Polymyxin: Isolation and Identification of Bacillus polymyxa and Differentiation of Polymyxin from Certain Known Antibiotics , 1947, Journal of bacteriology.